Denosumab Helps Boost BMD After MenopauseDenosumab Helps Boost BMD After Menopause

Postmenopausal women with low bone mineral density (BMD) who previously received bisphosphonates will have greater increases with denosumab (Prolia, Amgen) than with ibandronate. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
More News: Health | Men | Menopause | Women | Xgeva